title: [Colonic ulcer after prolongated administration of Kayexalate (sodium polystyrene sulfonate)].
authors.forename: Muriel
authors.initials: M
authors.lastname: Hourseau
authors.forename: Christine
authors.initials: C
authors.lastname: Lagorce-Pages
authors.forename: Robert
authors.initials: R
authors.lastname: Benamouzig
authors.forename: Olivier
authors.initials: O
authors.lastname: Tuil
authors.forename: Marie-Adèle
authors.initials: MA
authors.lastname: Ecomard
authors.forename: Leila
authors.initials: L
authors.lastname: Zemoura
authors.forename: Antoine
authors.initials: A
authors.lastname: Martin
mesh_terms: D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003108:Colonic Diseases / Q000139:chemically induced*; D004334:Drug Administration Schedule; D006801:Humans; D007676:Kidney Failure, Chronic; D008297:Male; D008875:Middle Aged; D011137:Polystyrenes / Q000009:adverse effects* / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D016868:Serratia Infections / Q000188:drug therapy; D012706:Serratia marcescens / Q000472:pathogenicity; D014456:Ulcer / Q000139:chemically induced*
chemical_list: D000890:Anti-Infective Agents; D011137:Polystyrenes; C003321:polystyrene sulfonic acid